This system with US patent ID (Pub. No .: US 2018/0299401 A1, Pub. Date: Oct. 18, 2018), has been introduced as a surgical assistant system in breast cancer surgery.
The CDP (Cancer Diagnostic Probe) system reveals the cancerous cells in the internal margins (cavity-side margin) within a few millimeters in 40 seconds, using a needle sensor with pathological calibration. This system has a clinical diagnostic classification matching with the pathological results of the tested tissues.

The CDP response peaks are based on the classification of the pathological system (Ductal intraepithelial neoplasia (DIN), Lobular intraepithelial neoplasia (LIN), and Fibro epithelial lesion (FEL) (according to the latest reported revisions)).
The distinctive ability of CDP to detect cancer cells in the internal margins (after tumor dissection) during surgery has been obtained for more than 1000 clinical breast margin samples with sensitivity and selectivity of 97% and 94%, respectively. This achievement marks the beginning of the introduction of electrotechnical onco-surgery in the clinical field.